Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Less than $10/month! Get more Watchlists, Portfolios, Custom Views and Chart Templates with Barchart Plus. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or

Aquestive Therapeutics Inc (AQST)

Aquestive Therapeutics Inc (AQST)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 351,035
  • Shares Outstanding, K 91,178
  • Annual Sales, $ 50,580 K
  • Annual Income, $ -7,870 K
  • EBIT $ -21 M
  • EBITDA $ -18 M
  • 60-Month Beta 2.62
  • Price/Sales 6.49
  • Price/Cash Flow N/A
  • Price/Book N/A

Options Overview Details

View History
  • Implied Volatility 207.20% ( +43.13%)
  • Historical Volatility 73.82%
  • IV Percentile 95%
  • IV Rank 59.64%
  • IV High 319.67% on 08/05/24
  • IV Low 41.00% on 08/15/24
  • Put/Call Vol Ratio 0.38
  • Today's Volume 369
  • Volume Avg (30-Day) 721
  • Put/Call OI Ratio 0.18
  • Today's Open Interest 16,136
  • Open Int (30-Day) 14,158

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 8 analysts offering recommendations.
Earnings Estimates - Current Qtr 12/31/24
See More
  • Average Estimate -0.14
  • Number of Estimates 5
  • High Estimate -0.13
  • Low Estimate -0.15
  • Prior Year -0.12
  • Growth Rate Est. (year over year) -16.67%

Price Performance

See More
Period Period Low Period High Performance
1-Month
3.38 +2.37%
on 12/18/24
5.28 -34.53%
on 12/02/24
-1.18 (-25.43%)
since 11/18/24
3-Month
3.38 +2.37%
on 12/18/24
5.80 -40.34%
on 10/30/24
-1.49 (-30.10%)
since 09/18/24
52-Week
1.84 +88.04%
on 12/21/23
6.23 -44.46%
on 03/18/24
+1.54 (+80.21%)
since 12/18/23

Most Recent Stories

More News
Aquestive Therapeutics Announces Positive FDA Feedback and Reaffirms NDA Submission Guidance for Anaphylmâ„¢ (epinephrine) Sublingual Film

AQST : 3.46 (-10.13%)
Aquestive Therapeutics to Participate in Two Upcoming Investor Conferences

AQST : 3.46 (-10.13%)
Aquestive Therapeutics: Q3 Earnings Snapshot

Aquestive Therapeutics: Q3 Earnings Snapshot

AQST : 3.46 (-10.13%)
Aquestive Therapeutics Reports Third Quarter 2024 Financial Results and Provides Business Update

AQST : 3.46 (-10.13%)
Aquestive Therapeutics to Present Subsequent Analysis of Pivotal Study for Anaphylmâ„¢ (epinephrine) Sublingual Film Demonstrating Comparable PK and PD Data to Epinephrine Injection Regardless of Variable Placement or Intraoral Movement at American...

AQST : 3.46 (-10.13%)
Aquestive Therapeutics Announces Positive Topline Results from Oral Allergy Syndrome (OAS) Challenge Study for Anaphylmâ„¢ (epinephrine) Sublingual Film

AQST : 3.46 (-10.13%)
Aquestive Therapeutics to Report Third Quarter 2024 Financial Results and Recent Business Highlights on November 4 and Host Conference Call on November 5 at 8:00 a.m. ET

AQST : 3.46 (-10.13%)
3 'Strong Buy' Penny Stocks to Grab Now for More Gains

Investing in penny stocks offers the potential for substantial returns over time, but it's a high-stakes endeavor best suited for bold investors who are willing to embrace the risks.

AQST : 3.46 (-10.13%)
$SPX : 5,872.16 (-2.95%)
WULF : 6.97 (-15.00%)
^BTCUSD : 102,350.14 (+1.15%)
PL : 3.87 (-7.86%)
GOOGL : 188.40 (-3.59%)
The Future of Medicine: Drug Delivery Innovations Leading a $700 Billion Market

Issued on behalf of BioVaxys Technology Corp. VANCOUVER – USA News Group – In the field of medicine, many...

LEXX : 2.11 (+1.44%)
BIOV.CN : 0.0600 (unch)
BVAXF : 0.0455 (+7.06%)
TFFP : 0.0650 (-60.05%)
DNTH : 23.28 (-4.08%)
AQST : 3.46 (-10.13%)
Aquestive Therapeutics: Q2 Earnings Snapshot

Aquestive Therapeutics: Q2 Earnings Snapshot

AQST : 3.46 (-10.13%)

Business Summary

Aquestive Therapeutics, Inc. is a specialty pharmaceutical company. It commercializes medicines to solve critical health care problems as well as engages on late-stage proprietary product pipeline which focuses on the treatment of diseases of central nervous system. Aquestive Therapeutics, Inc. is based...

See More

Key Turning Points

3rd Resistance Point 4.28
2nd Resistance Point 4.09
1st Resistance Point 3.77
Last Price 3.46
1st Support Level 3.26
2nd Support Level 3.07
3rd Support Level 2.75

See More

52-Week High 6.23
Fibonacci 61.8% 4.55
Fibonacci 50% 4.03
Fibonacci 38.2% 3.52
Last Price 3.46
52-Week Low 1.84

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.

Free Barchart Webinar